Toggle navigation
About
Abstract
Editorial Board
Publication Schedule
Subscription & Newsletter
Contact
Issues
This issue
25-3
All issues
Download PDF
Download EPUB
Editor's Selection
This issue
25-3
Browse by topic
Browse by contributor
Dialogue & Opinion
Abstracts
Abstracts
Search
Classification List
Abstracted Journals
Index of Authors
News & Reports
Home
Abstracts
Index of Authors
Author #59338
advertisement
Xie Z
29
Showing records 1 to 25 |
Display all abstracts from
Xie Z
127117
Functionally deficient UBOX5 variants and primary angle-closure glaucoma
Li Z
Nature communications
2025; 16: 7620
128148
Unlocking the potential of GLP-1 receptor agonists in ocular therapeutics: from molecular pathways to clinical impact
Xie Z
Frontiers in pharmacology
2025; 16: 1618079
128209
Intraocular pressure is a promising target for myopia control
Wang P; Kong K
Journal of translational medicine
2025; 23: 556
127117
Functionally deficient UBOX5 variants and primary angle-closure glaucoma
Chng WL
Nature communications
2025; 16: 7620
128148
Unlocking the potential of GLP-1 receptor agonists in ocular therapeutics: from molecular pathways to clinical impact
Yang Z
Frontiers in pharmacology
2025; 16: 1618079
127117
Functionally deficient UBOX5 variants and primary angle-closure glaucoma
Liu Z
Nature communications
2025; 16: 7620
128148
Unlocking the potential of GLP-1 receptor agonists in ocular therapeutics: from molecular pathways to clinical impact
Tian D
Frontiers in pharmacology
2025; 16: 1618079
127117
Functionally deficient UBOX5 variants and primary angle-closure glaucoma
Do T
Nature communications
2025; 16: 7620
128148
Unlocking the potential of GLP-1 receptor agonists in ocular therapeutics: from molecular pathways to clinical impact
Chen Y
Frontiers in pharmacology
2025; 16: 1618079
128209
Intraocular pressure is a promising target for myopia control
Jiang J; Xie Z
Journal of translational medicine
2025; 23: 556
127117
Functionally deficient UBOX5 variants and primary angle-closure glaucoma
Nakano M; Chen LJ
Nature communications
2025; 16: 7620
128209
Intraocular pressure is a promising target for myopia control
Lin F
Journal of translational medicine
2025; 23: 556
127117
Functionally deficient UBOX5 variants and primary angle-closure glaucoma
Loo Y
Nature communications
2025; 16: 7620
128209
Intraocular pressure is a promising target for myopia control
Song Y
Journal of translational medicine
2025; 23: 556
127117
Functionally deficient UBOX5 variants and primary angle-closure glaucoma
Loo Y
Nature communications
2025; 16: 7620
128209
Intraocular pressure is a promising target for myopia control
Fang X
Journal of translational medicine
2025; 23: 556
127117
Functionally deficient UBOX5 variants and primary angle-closure glaucoma
Chan ASY; Topouzis F
Nature communications
2025; 16: 7620
128209
Intraocular pressure is a promising target for myopia control
Jin L
Journal of translational medicine
2025; 23: 556
127117
Functionally deficient UBOX5 variants and primary angle-closure glaucoma
Nongpiur ME
Nature communications
2025; 16: 7620
128209
Intraocular pressure is a promising target for myopia control
Li F; Wang W
Journal of translational medicine
2025; 23: 556
127117
Functionally deficient UBOX5 variants and primary angle-closure glaucoma
Ozaki M; Nakano S
Nature communications
2025; 16: 7620
128209
Intraocular pressure is a promising target for myopia control
Du S
Journal of translational medicine
2025; 23: 556
127117
Functionally deficient UBOX5 variants and primary angle-closure glaucoma
Kubota T
Nature communications
2025; 16: 7620
128209
Intraocular pressure is a promising target for myopia control
Shi Z; Zeng J
Journal of translational medicine
2025; 23: 556
127117
Functionally deficient UBOX5 variants and primary angle-closure glaucoma
Perera SA; Husain R
Nature communications
2025; 16: 7620
«
1
2
»
Issue
25-3
Table of Contents
Editor's Selection
PDF
EPUB
Change Issue
26-1
25-4
25-3
25-2
25-1
24-4
24-3
24-1/2
23-4
23-3
23-2
23-1
22-4
22-3
22-2
22-1
21-4
21-3
21-2
21-1
20-4
20-3
20-2
20-1
19-4
19-3
19-2
19-1
18-4
18-3
18-2
18-1
17-4
17-3
17-2
17-1
16-4
16-3
16-2
16-1
15-4
15-3
15-2
15-1
14-4
14-3
14-2
14-1
13-4
13-3
13-2
13-1
12-4
12-3
12-2
12-1
11-4
11-3
11-2
11-1
10-4
10-3
10-2
10-1
9-4
9-3
9-2
9-1
8-4
8-3
8-2
8-1
7-3
7-2
7-1
6-3
6-2
6-1
5-3
5-2
5-1
4-3
4-2
4-1
3-3
3-2
3-1
2-3
2-2
2-1
1-3
1-2
1-1
advertisement
We would like to use Google Analytics to see which parts of the review are read. It is only used to count visits, never for advertising.
Privacy statement
Decline
Accept